A Randomised Comparative study to evaluate the performance of Ambu Auragain and the Laryngeal Mask Airway Supreme
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/07/055390
- Lead Sponsor
- JJM Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Duration of surgeries less than 2 hours
ASA I and II
Posted for elective surgery under general anaesthesia in supine position
Exclusion Criteria
Patients with predicted difficult airway
Patients with any pathology in neck, upper respiratory or alimentary tract
BMI more than 30kg/me
Patients with history of obstructive sleep apnea,lung diseases or bleeding disorders
Patients with full stomach or history of oesophageal reflux
Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of attempts, time taken for insertion(in seconds) and ease of insertion <br/ ><br>Oropharyngeal leak pressure(in cm H2O) <br/ ><br>Ease of insertion of Nasogastric tube <br/ ><br>Hemodynamic changes(heart rate, saturation and blood pressure) <br/ ><br>Timepoint: <br/ ><br>Hemodynamic changes(heart rate, saturation and blood pressure)at 1min, 5min and 10 min after Supraglottic Airway Device insertion <br/ ><br>
- Secondary Outcome Measures
Name Time Method Intraoperative desaturation or laryngospasm <br/ ><br>Blood stain on device during withdrawal <br/ ><br>Postoperative sore throat, hoarseness or dysphagiaTimepoint: 1 hour and 6 hours postoperatively